Why I’d Steer Clear of Aurora Cannabis Right Now

Here’s why I wouldn’t touch Aurora Cannabis (TSX:ACB)(NYSE:ACB) right now. There are much better options out there today.

| More on:
edit Jars of marijuana

Image source: Getty Images

The cannabis market is hot now. Forget that, it’s red-hot at the moment.

Cannabis plays have taken off, though not in sync as they previously have. It appears investors are starting to hand-pick names more than ever before. And unlike some of my other top cannabis picks, Aurora Cannabis (TSX:ACB)(NYSE:ACB) hasn’t done as well as some of its peers in reaching for its 2019 highs.

Here’s why I think that’s the case, and why I’d recommend investors consider other cannabis names right now.

Lackluster earnings continue to disappoint stakeholders

Earnings haven’t really been that important to cannabis plays in recent years. During the run-up in cannabis valuations in 2018 and 2019, revenue growth is all that mattered.

However, of late, investors appear to be more concerned with not only top-line growth. Revenue and earnings quality matters more than ever before.

Accordingly, finding cannabis stocks with a strong financial standing is more important than ever. And on this front, Aurora hasn’t impressed investors.

The company recently posted earnings that missed the mark, as far as investors an analysts are concerned. The company’s revenue of $55 million was down 25% year over year. This comes amid a spike in cannabis sales domestically.

These numbers also greatly missed analyst expectations of $69 million this past quarter. Accordingly, it appears investors are focusing on other cannabis plays, with a greater focus on U.S. MSOs with greater growth potential over the medium- to long-term.

The company did post an adjusted EBITDA of nearly $24 million this past quarter. This was an improvement over last year, albeit the company did post a wider-than-expected loss.

Aurora’s 53% drop in recreational pot sales was disappointing to even the most bearish investors. Accordingly, it’s hard to look on the bright side with this stock right now.

Bottom line

I think the rather bearish note analysts are taking with Aurora right now is warranted. Among the Canadian cannabis sector, I haven’t been bullish on Aurora in the past. I view this company as a tertiary player in a sector with better options.

Accordingly, this is a stock I wouldn’t touch right now.

I think there are much better options from a growth and fundamentals standpoint right now. And with fundamentals finally starting to matter, this is more important than ever for investors to consider.

Investors seeking growth in the cannabis space would be much better-served checking out other high-quality U.S. MSOs right now. My top cannabis pick today is Curaleaf  for this reason.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »